- Home
- All Stock List
- NSE
- Rossari Biotech Ltd Share Price
615.70
-5.60 (-0.90%)
-
Underperforms Index
-9.96%
Return (1Y)
Underperformed Nifty 50 by 11.78%
-
More Volatile
2.02%
Standard Deviation (1Y)
Higher than Nifty 50 by 1.14%
-
Not so consistent
5/12
Months
underperformed Nifty 50
-
AxisDirect View
No View
973
569
News & Announcements
-
Rossari Biotech slides after PAT tumble 8% YoY to Rs 32 cr in Q3 FY25
22 - Jan - 2025 12:00 AM | 51 days ago
However, revenue from operations jumped 10.55% to Rs 512.73 crore in the third quarter of FY25 as against Rs 463.77 crore posted in the corresponding quarter last year.
Profit before tax stood at Rs 42.38 crore in the quarter ended 31 December 2024, down 11.30% as against Rs 47.78 crore recorded in Q3 FY24.
Total expenses advanced 12.32% to Rs 471.23 crore during the quarter. Cost of material consumed stood at Rs 321.48 crore (down 17.78% YoY), employee benefit expenses stood at Rs 35.69 crore (up 37.07%) while finance cost was at Rs 4.94 crore (up 14.35% YoY), during the period under review.
On nine-month basis, the company's standalone net profit rose 5.56% to Rs 101.93 crore on 10.52% increase in revenue to Rs 1,500.7 crore in 9M FY25 over 9M FY24.
Rossari Biotech is a specialty chemical manufacturer and offers tailor-made solutions for home, personal care and performance chemicals (HPPC), textile speciality chemicals and animal health and nutrition (AHN).
Powered by Capital Market - Live News
-
Rossari Biotech consolidated net profit declines 7.82% in the December 2024 quarter
22 - Jan - 2025 12:00 AM | 51 days ago
Net profit of Rossari Biotech declined 7.82% to Rs 31.70 crore in the quarter ended December 2024 as against Rs 34.39 crore during the previous quarter ended December 2023. Sales rose 10.56% to Rs 512.73 crore in the quarter ended December 2024 as against Rs 463.77 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 512.73 463.77 11 OPM % 12.63 13.73 - PBDT 60.70 62.87 -3 PBT 42.38 47.78 -11 NP 31.70 34.39 -8 Powered by Capital Market - Live News
-
Rossari Biotech shifts registered office
52 days ago
The board of Rossari Biotech at its meeting held on 21 January 2025 has approved change in registered office from 201 A - B, 2nd Floor, Akruti Corporate Park, L.B.S Marg, Next to GE Gardens, Kanjurmarg (W), Mumbai - 400078 to Rossari House, Golden Oak, LBS Marg, Surya Nagar, Opp. Mahindra Showroom, Vikhroli (West), Mumbai Maharashtra, India, 400079 effective from 01 February 2025.
Powered by Capital Market - Live News
-
Rossari Biotech consolidated net profit declines 7.82% in the December 2024 quarter
22 - Jan - 2025 12:00 AM | 51 days ago
Net profit of Rossari Biotech declined 7.82% to Rs 31.70 crore in the quarter ended December 2024 as against Rs 34.39 crore during the previous quarter ended December 2023. Sales rose 10.56% to Rs 512.73 crore in the quarter ended December 2024 as against Rs 463.77 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 512.73 463.77 11 OPM % 12.63 13.73 - PBDT 60.70 62.87 -3 PBT 42.38 47.78 -11 NP 31.70 34.39 -8 Powered by Capital Market - Live News
-
Rossari Biotech shifts registered office
52 days ago
The board of Rossari Biotech at its meeting held on 21 January 2025 has approved change in registered office from 201 A - B, 2nd Floor, Akruti Corporate Park, L.B.S Marg, Next to GE Gardens, Kanjurmarg (W), Mumbai - 400078 to Rossari House, Golden Oak, LBS Marg, Surya Nagar, Opp. Mahindra Showroom, Vikhroli (West), Mumbai Maharashtra, India, 400079 effective from 01 February 2025.
Powered by Capital Market - Live News
-
Rossari Biotech has allotted 7,500 equity shares under ESOP on 21 January 2025. Consequently, the paid up equity share capital has increased to Rs. 11,07,27,532 consisting of 55363766 equity shares of Rs. 2/- each.
Powered by Capital Market - Live News
-
Rossari Biotech slides after PAT tumble 8% YoY to Rs 32 cr in Q3 FY25
22 - Jan - 2025 12:00 AM | 51 days ago
However, revenue from operations jumped 10.55% to Rs 512.73 crore in the third quarter of FY25 as against Rs 463.77 crore posted in the corresponding quarter last year.
Profit before tax stood at Rs 42.38 crore in the quarter ended 31 December 2024, down 11.30% as against Rs 47.78 crore recorded in Q3 FY24.
Total expenses advanced 12.32% to Rs 471.23 crore during the quarter. Cost of material consumed stood at Rs 321.48 crore (down 17.78% YoY), employee benefit expenses stood at Rs 35.69 crore (up 37.07%) while finance cost was at Rs 4.94 crore (up 14.35% YoY), during the period under review.
On nine-month basis, the company's standalone net profit rose 5.56% to Rs 101.93 crore on 10.52% increase in revenue to Rs 1,500.7 crore in 9M FY25 over 9M FY24.
Rossari Biotech is a specialty chemical manufacturer and offers tailor-made solutions for home, personal care and performance chemicals (HPPC), textile speciality chemicals and animal health and nutrition (AHN).
Powered by Capital Market - Live News
-
Rossari Biotech consolidated net profit declines 7.82% in the December 2024 quarter
22 - Jan - 2025 12:00 AM | 51 days ago
Net profit of Rossari Biotech declined 7.82% to Rs 31.70 crore in the quarter ended December 2024 as against Rs 34.39 crore during the previous quarter ended December 2023. Sales rose 10.56% to Rs 512.73 crore in the quarter ended December 2024 as against Rs 463.77 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 512.73 463.77 11 OPM % 12.63 13.73 - PBDT 60.70 62.87 -3 PBT 42.38 47.78 -11 NP 31.70 34.39 -8 Powered by Capital Market - Live News
-
Rossari Biotech shifts registered office
52 days ago
The board of Rossari Biotech at its meeting held on 21 January 2025 has approved change in registered office from 201 A - B, 2nd Floor, Akruti Corporate Park, L.B.S Marg, Next to GE Gardens, Kanjurmarg (W), Mumbai - 400078 to Rossari House, Golden Oak, LBS Marg, Surya Nagar, Opp. Mahindra Showroom, Vikhroli (West), Mumbai Maharashtra, India, 400079 effective from 01 February 2025.
Powered by Capital Market - Live News
-
Rossari Biotech has allotted 7,500 equity shares under ESOP on 21 January 2025. Consequently, the paid up equity share capital has increased to Rs. 11,07,27,532 consisting of 55363766 equity shares of Rs. 2/- each.
Powered by Capital Market - Live News
-
Rossari Biotech slides after PAT tumble 8% YoY to Rs 32 cr in Q3 FY25
22 - Jan - 2025 12:00 AM | 51 days ago
However, revenue from operations jumped 10.55% to Rs 512.73 crore in the third quarter of FY25 as against Rs 463.77 crore posted in the corresponding quarter last year.
Profit before tax stood at Rs 42.38 crore in the quarter ended 31 December 2024, down 11.30% as against Rs 47.78 crore recorded in Q3 FY24.
Total expenses advanced 12.32% to Rs 471.23 crore during the quarter. Cost of material consumed stood at Rs 321.48 crore (down 17.78% YoY), employee benefit expenses stood at Rs 35.69 crore (up 37.07%) while finance cost was at Rs 4.94 crore (up 14.35% YoY), during the period under review.
On nine-month basis, the company's standalone net profit rose 5.56% to Rs 101.93 crore on 10.52% increase in revenue to Rs 1,500.7 crore in 9M FY25 over 9M FY24.
Rossari Biotech is a specialty chemical manufacturer and offers tailor-made solutions for home, personal care and performance chemicals (HPPC), textile speciality chemicals and animal health and nutrition (AHN).
Powered by Capital Market - Live News
-
Rossari Biotech consolidated net profit declines 7.82% in the December 2024 quarter
22 - Jan - 2025 12:00 AM | 51 days ago
Net profit of Rossari Biotech declined 7.82% to Rs 31.70 crore in the quarter ended December 2024 as against Rs 34.39 crore during the previous quarter ended December 2023. Sales rose 10.56% to Rs 512.73 crore in the quarter ended December 2024 as against Rs 463.77 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 512.73 463.77 11 OPM % 12.63 13.73 - PBDT 60.70 62.87 -3 PBT 42.38 47.78 -11 NP 31.70 34.39 -8 Powered by Capital Market - Live News
-
Rossari Biotech shifts registered office
52 days ago
The board of Rossari Biotech at its meeting held on 21 January 2025 has approved change in registered office from 201 A - B, 2nd Floor, Akruti Corporate Park, L.B.S Marg, Next to GE Gardens, Kanjurmarg (W), Mumbai - 400078 to Rossari House, Golden Oak, LBS Marg, Surya Nagar, Opp. Mahindra Showroom, Vikhroli (West), Mumbai Maharashtra, India, 400079 effective from 01 February 2025.
Powered by Capital Market - Live News
-
Rossari Biotech consolidated net profit declines 7.82% in the December 2024 quarter
22 - Jan - 2025 12:00 AM | 51 days ago
Net profit of Rossari Biotech declined 7.82% to Rs 31.70 crore in the quarter ended December 2024 as against Rs 34.39 crore during the previous quarter ended December 2023. Sales rose 10.56% to Rs 512.73 crore in the quarter ended December 2024 as against Rs 463.77 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 512.73 463.77 11 OPM % 12.63 13.73 - PBDT 60.70 62.87 -3 PBT 42.38 47.78 -11 NP 31.70 34.39 -8 Powered by Capital Market - Live News
-
Rossari Biotech shifts registered office
52 days ago
The board of Rossari Biotech at its meeting held on 21 January 2025 has approved change in registered office from 201 A - B, 2nd Floor, Akruti Corporate Park, L.B.S Marg, Next to GE Gardens, Kanjurmarg (W), Mumbai - 400078 to Rossari House, Golden Oak, LBS Marg, Surya Nagar, Opp. Mahindra Showroom, Vikhroli (West), Mumbai Maharashtra, India, 400079 effective from 01 February 2025.
Powered by Capital Market - Live News
-
Rossari Biotech has allotted 7,500 equity shares under ESOP on 21 January 2025. Consequently, the paid up equity share capital has increased to Rs. 11,07,27,532 consisting of 55363766 equity shares of Rs. 2/- each.
Powered by Capital Market - Live News
Stock Trivia
FII shareholding in Rossari Biotech Ltd has decreased by -9.81% since past 1 Year
MF shareholding in Rossari Biotech Ltd has decreased by -4.86% since past 1 Year
FII shareholding in Rossari Biotech Ltd has decreased by -9.81% since past 1 Year
MF shareholding in Rossari Biotech Ltd has decreased by -4.86% since past 1 Year
FII shareholding in Rossari Biotech Ltd has decreased by -9.81% since past 1 Year
MF shareholding in Rossari Biotech Ltd has decreased by -4.86% since past 1 Year
